Due to COVID-19, Reach4Sky is moving our swim events to 2022
Three FDA-approved treatments are changing the course of SMA.
Genentech receives FDA approval of Evrysdi, an oral medication, for spinal muscular atrophy for adult patients and children two+ months.
AveXis receives FDA approval of Zolgensma, a gene therapy, for spinal muscular atrophy for patients under two years of age.
Biogen receives FDA approval of Spinraza, making it the first-ever treatment for all patients with spinal muscular atrophy.
Copyright © 2021 Reach4Sky.com - All Rights Reserved.
Powered by GoDaddy